Gary Littlejohn
Plus aucun poste en cours
Fortune : 7 910 $ au 31/03/2024
Profil
Gary Littlejohn served as the Chief Executive Officer & Director at Helix BioPharma Corp.
from 2015 to 2016.
He was also the Director at Montréal Exchange, Inc. from 1998 to 2000.
From 2000 to 2006, he worked as the Chief Financial Officer at Ecopia BioSciences, Inc. He was the Managing Director-Investment Banking at Desjardins Securities, Inc. and held Principal positions at Merrill Lynch & Co., Inc., Teleglobe, Inc., Bombardier, Inc., TD Securities, Inc., and BCE.
He also served as a Director at Aegera Therapeutics, Inc., Aegera Pharmaceuticals, and Arab National Investment Co. Additionally, he was an Independent Director at Theratechnologies, Inc. from 2018 to 2023.
Mr. Littlejohn received his undergraduate degree and MBA from McGill University in 1979 and 1982, respectively.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
THERATECHNOLOGIES INC.
0,01% | 06/04/2023 | 4 765 ( 0,01% ) | 7 910 $ | 31/03/2024 |
Anciens postes connus de Gary Littlejohn
| Sociétés | Poste | Fin |
|---|---|---|
| THERATECHNOLOGIES INC. | Director/Board Member | 21/07/2023 |
| HELIX BIOPHARMA CORP. | Chief Executive Officer | 18/01/2016 |
Arab National Bank Investment Co.
 Arab National Bank Investment Co. Investment ManagersFinance Arab National Bank Investment Co. (ANB Invest) is wholly-owned subsidiary of Arab National Bank in Saudi Arabia, acting as its sole investment arm. Founded in 2008, the firm is headquartered in Riyadh and offers the full spectrum of investment services both conventional and Shariah-compliant, to all client categories including private & institutional investors. ANB Invest’s asset management division offers a wide range of mutual funds in addition to private portfolios management services in accordance with the various risk appetites and liquidity needs of its individual & institutional clients. | Chief Executive Officer | 01/09/2014 |
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Director/Board Member | 01/01/2009 |
Ecopia BioSciences, Inc.
 Ecopia BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Ecopia is finding novel anticancer therapies from soil-dwelling micro organisms that are as of this day one of the most prolific sources of these drugs. Their current focus is ECO-4601, a new small molecule that crosses the blood brain barrier and is effective in significantly inhibiting primary tumor growth in the brain. Just like well-known chemotherapies such as doxorubicin and daunorubicin, ECO-4601 comes from microorganisms that live in common soil. ECO-4601 represents a new chemical class that is the fruit of a very unique drug discovery platform called the Decipher® technology | Director of Finance/CFO | 01/01/2006 |
Formation de Gary Littlejohn
| McGill University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BOMBARDIER INC. | Electronic Technology |
| HELIX BIOPHARMA CORP. | Health Technology |
| THERATECHNOLOGIES INC. | Health Technology |
| Entreprise privées | 12 |
|---|---|
Merrill Lynch & Co., Inc. /Old/
 Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Merrill Lynch & Co., Inc. provided wealth management, securities trading and sales, corporate finance and investment banking services. Merrill Lynch was a global trader and underwriter of securities and derivatives across a range of asset classes and serve as a strategic advisor to governments, institutions and individuals worldwide. The company was founded in 1913 and was headquartered in Charlotte, NC. | Finance |
Teleglobe, Inc.
 Teleglobe, Inc. Major TelecommunicationsCommunications Teleglobe, Inc. provides telecommunications services. It offers voice, data and internet protocol virtual private network. The company was founded in 2003 and is headquartered in Montréal, Canada. | Communications |
Ecopia BioSciences, Inc.
Ecopia BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Ecopia is finding novel anticancer therapies from soil-dwelling micro organisms that are as of this day one of the most prolific sources of these drugs. Their current focus is ECO-4601, a new small molecule that crosses the blood brain barrier and is effective in significantly inhibiting primary tumor growth in the brain. Just like well-known chemotherapies such as doxorubicin and daunorubicin, ECO-4601 comes from microorganisms that live in common soil. ECO-4601 represents a new chemical class that is the fruit of a very unique drug discovery platform called the Decipher® technology | Health Technology |
Montréal Exchange, Inc.
 Montréal Exchange, Inc. Investment Banks/BrokersFinance Montréal Exchange, Inc. engages in the operation and development of market and clearing services for Canadian and international clients and to commercialize internally developed technology solutions. The Group operates in two segments, namely, Exchange and Clearing House. The Exchange segment acts as the only standardized financial derivatives exchange in Canada, providing a complete range of equity, index and interest rate derivatives. The Clearing House segment acts as clearing house and guarantor for derivative instruments traded at the MX and certain other derivative instruments from the over-the-counter market. The company is headquartered in Montreal, Canada. | Finance |
TD Securities, Inc.
 TD Securities, Inc. Investment Banks/BrokersFinance TD Securities, Inc. is a Canadian broker/dealer headquartered in Toronto, Ontario. The firm is a subsidiary of The Toronto-Dominion Bank (NYSE, TSE: TD). TD Securities provides a wide range of capital market products and services to corporate, government and institutional clients. Their services also include the underwriting and distribution of new debt and equity issues, providing advice on strategic acquisitions and divestitures and executing daily trading and investment needs. The firm’s equity group provides research coverage of various sectors. Their fixed-income group provides a full range of underwriting sales and trading products for Canadian, US and European debt issuers and investors. | Finance |
Bce
 Bce Information Technology ServicesTechnology Services BCE is a British company that provides software development services. | Technology Services |
Desjardins Securities, Inc.
 Desjardins Securities, Inc. Investment Banks/BrokersFinance Desjardins Securities, Inc. is the broker/dealer arm of the Desjardins Holding Financier, Inc., ultimately held by Le Mouvement des caisses Desjardins in Canada. Founded in 1991, the firm is headquartered in Montréal and has an additional office in Toronto. Desjardins Securities offers businesses and institutions with a complete range of securities brokerage products and services through its investment advisors and its Disnat Online Brokerage division. The firm is an approved participant on the Montreal Exchange and the Toronto Stock Exchange, as well as a participating member of the TSX Venture Exchange. In addition, Desjardins Securities is a member of both the Investment Industry Regulatory Organization of Canada (IIROC) and the Canadian Investor Protection Fund (CIPF). | Finance |
Equity Bank (Andover, Kansas)
 Equity Bank (Andover, Kansas) Regional BanksFinance Equity Bank, Inc. provides banking services. Its services include personal, online, business banking and other loan services. The company was founded in 1985 and is headquartered in Andover, KS. | Finance |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Health Technology |
Arab National Bank Investment Co.
Arab National Bank Investment Co. Investment ManagersFinance Arab National Bank Investment Co. (ANB Invest) is wholly-owned subsidiary of Arab National Bank in Saudi Arabia, acting as its sole investment arm. Founded in 2008, the firm is headquartered in Riyadh and offers the full spectrum of investment services both conventional and Shariah-compliant, to all client categories including private & institutional investors. ANB Invest’s asset management division offers a wide range of mutual funds in addition to private portfolios management services in accordance with the various risk appetites and liquidity needs of its individual & institutional clients. | Finance |
| Arab National Investment Co. | |
| Aegera Pharmaceuticals |
